Articles > GSK, AMGN, NG, BIIB, GLUE showing five-day upward surge
GSK is trading UP for the last 5 days, and it at trading at $39.98 with volume of 1,792,835 and a one day change of $0.68 (1.73%). GSK plc has a 52-week low of 31.88 and a 52-week high of $44.42. The business's 50-day moving average price is $35.03 and its 200 day moving average price is $37.58. The firm has a market cap of $80 million, a P/E ratio of 16.57, and a beta of 0.29.
NEW YORK, NY / ACCESS Newswire / March 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc ("GSK" or the "Company") (NYSE:GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. NEW YORK CITY, NY / ACCESS Newswire / March 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GSK plc ("GSK" or "the Company") (NYSE:GSK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GSK American Depositary Receipts ("ADRs") between February 5, 2020 and August 14, 2022, both dates inclusive (the "Class Period"). NEW YORK , March 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GSK investors who were adversely affected by alleged securities fraud between February 5, 2020 and August 14, 2022. Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Analyst Blog.
For more information on GSK:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
AMGN is trading UP for the last 5 days, and it at trading at $325.74 with volume of 834,293 and a one day change of $7.92 (2.49%). Amgen Inc. has a 52-week low of 255.94 and a 52-week high of $338.99. The business's 50-day moving average price is $282.64 and its 200 day moving average price is $301.47. The firm has a market cap of $170 million, a P/E ratio of 44.24, and a beta of 0.52.
Dividend investors don't buy shares of companies hoping they will suspend their payouts soon. The longer a corporation maintains its dividend program, the more attractive it is to income seekers, all else being equal.
For more information on AMGN:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
NG is trading UP for the last 5 days, and it at trading at $3.43 with volume of 740,026 and a one day change of $0.09 (2.54%). NovaGold Resources Inc. has a 52-week low of 2.49 and a 52-week high of $4.88. The business's 50-day moving average price is $3.21 and its 200 day moving average price is $3.70. The firm has a market cap of $1 million, a P/E ratio of 0.00, and a beta of 1.10.
For more information on NG:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
BIIB is trading UP for the last 5 days, and it at trading at $152.42 with volume of 532,712 and a one day change of $5.05 (3.42%). Biogen Inc. has a 52-week low of 132.15 and a 52-week high of $238.00. The business's 50-day moving average price is $144.26 and its 200 day moving average price is $184.59. The firm has a market cap of $21 million, a P/E ratio of 27.69, and a beta of 0.01.
For more information on BIIB:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
GLUE is trading UP for the last 5 days, and it at trading at $6.46 with volume of 215,579 and a one day change of $0.17 (2.62%). Monte Rosa Therapeutics, Inc. has a 52-week low of 3.32 and a 52-week high of $12.40. The business's 50-day moving average price is $6.29 and its 200 day moving average price is $5.93. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 1.50.
If the cancer space appeals to you, it's time to consider stocks like Novartis, Exact Sciences and Monte Rosa.
For more information on GLUE:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
GSK, AMGN, NG, BIIB, GLUE showing five-day upward surge
By KlickAnalytics Data Insights | March 7, 2025 10:42AM ET
GSK plc (GSK)
GSK is trading UP for the last 5 days, and it at trading at $39.98 with volume of 1,792,835 and a one day change of $0.68 (1.73%). GSK plc has a 52-week low of 31.88 and a 52-week high of $44.42. The business's 50-day moving average price is $35.03 and its 200 day moving average price is $37.58. The firm has a market cap of $80 million, a P/E ratio of 16.57, and a beta of 0.29.
Top news headlines for GSK
For more information on GSK:
Amgen Inc. (AMGN)
AMGN is trading UP for the last 5 days, and it at trading at $325.74 with volume of 834,293 and a one day change of $7.92 (2.49%). Amgen Inc. has a 52-week low of 255.94 and a 52-week high of $338.99. The business's 50-day moving average price is $282.64 and its 200 day moving average price is $301.47. The firm has a market cap of $170 million, a P/E ratio of 44.24, and a beta of 0.52.
Top news headlines for AMGN
For more information on AMGN:
NovaGold Resources Inc. (NG)
NG is trading UP for the last 5 days, and it at trading at $3.43 with volume of 740,026 and a one day change of $0.09 (2.54%). NovaGold Resources Inc. has a 52-week low of 2.49 and a 52-week high of $4.88. The business's 50-day moving average price is $3.21 and its 200 day moving average price is $3.70. The firm has a market cap of $1 million, a P/E ratio of 0.00, and a beta of 1.10.
For more information on NG:
Biogen Inc. (BIIB)
BIIB is trading UP for the last 5 days, and it at trading at $152.42 with volume of 532,712 and a one day change of $5.05 (3.42%). Biogen Inc. has a 52-week low of 132.15 and a 52-week high of $238.00. The business's 50-day moving average price is $144.26 and its 200 day moving average price is $184.59. The firm has a market cap of $21 million, a P/E ratio of 27.69, and a beta of 0.01.
For more information on BIIB:
Monte Rosa Therapeutics, Inc. (GLUE)
GLUE is trading UP for the last 5 days, and it at trading at $6.46 with volume of 215,579 and a one day change of $0.17 (2.62%). Monte Rosa Therapeutics, Inc. has a 52-week low of 3.32 and a 52-week high of $12.40. The business's 50-day moving average price is $6.29 and its 200 day moving average price is $5.93. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 1.50.
Top news headlines for GLUE
For more information on GLUE:
This article was generated by KlickAnalytics data insight content engine.
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.